Teva Branded Pharmaceutical Products R&d Llc

This early-phase trial tests a new drug called TEV-56278, alone or with pembrolizumab, in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. About 240 p…

This study tests an oral drug called TEV-56286 in 350 adults with multiple system atrophy (MSA), a rare brain disease that affects movement and body functions. The goal is to see if the drug can slow disease progression and improve symptoms over 48 weeks. Participants will be ran…

This study tests a new inhaler that combines two common asthma medicines (fluticasone and albuterol) to see if it works better than each medicine alone or a placebo. About 724 people aged 12 and older with asthma will use the inhaler four times daily for four weeks. The goal is t…